Tenaya Therapeutics
Stock Forecast, Prediction & Price Target
Tenaya Therapeutics Financial Estimates
Tenaya Therapeutics Revenue Estimates
Tenaya Therapeutics EBITDA Estimates
Tenaya Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $3.83M Low: $2.66M High: $4.99M avg. 0% | Avg: $34.04M Low: $26.81M High: $41.26M avg. 788.01% | Avg: $226.13M Low: $178.16M High: $274.10M avg. 564.30% | Avg: $812.14M Low: $639.86M High: $984.41M avg. 259.14% |
Net Income
% change YoY
| $-69.65M N/A | $-123.66M -77.54% | $-124.08M -0.34% | Avg: $-136.34M Low: $-139.45M High: $-81.90M avg. -9.88% | Avg: $-134.23M Low: $-130.60M High: $-60.50M avg. 1.54% | Avg: $3.09M Low: $2.24M High: $3.95M avg. 102.30% | Avg: $290.90M Low: $210.68M High: $371.11M avg. 9286.90% |
EBITDA
% change YoY
| $-72.80M N/A | $-125.62M -72.54% | $-122.50M 2.47% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.69 N/A | -$2.76 -63.31% | -$1.68 39.13% | Avg: -$1.56 Low: -$1.89 High: -$1.11 avg. 7.34% | Avg: -$1.43 Low: -$1.77 High: -$0.82 avg. 8.00% | Avg: $0.04 Low: $0.03 High: $0.05 avg. 102.93% | Avg: $3.94 Low: $2.86 High: $5.03 avg. 9286.90% |
Operating Expenses
% change YoY
| $72.80M N/A | $125.62M 72.54% | $131.19M 4.43% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Tenaya Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 2345.21% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -139.45M, average is -136.34M and high is -81.90M.
What is Tenaya Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 402.86% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $2.66M, average is $3.83M and high is $4.99M.
What is Tenaya Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 2351.29% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$1.89, average is -$1.56 and high is $-1.11.